These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9701680)

  • 41. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
    Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
    J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new algorithm for predicting time to disease endpoints in Alzheimer's disease patients.
    Razlighi QR; Stallard E; Brandt J; Blacker D; Albert M; Scarmeas N; Kinosian B; Yashin AI; Stern Y
    J Alzheimers Dis; 2014; 38(3):661-8. PubMed ID: 24064468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 18F-FDG PET Is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism.
    Hellwig S; Frings L; Amtage F; Buchert R; Spehl TS; Rijntjes M; Tüscher O; Weiller C; Weber WA; Vach W; Meyer PT
    J Nucl Med; 2015 Oct; 56(10):1541-6. PubMed ID: 26229141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical presentation of Moroccan cases with Alzheimer's disease].
    El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
    Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.
    Rodriguez-Vieitez E; Saint-Aubert L; Carter SF; Almkvist O; Farid K; Schöll M; Chiotis K; Thordardottir S; Graff C; Wall A; Långström B; Nordberg A
    Brain; 2016 Mar; 139(Pt 3):922-36. PubMed ID: 26813969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Body Mass Index and Mortality Rate in Korean Patients with Alzheimer's Disease.
    Jang H; Kim JH; Choi SH; Lee Y; Hong CH; Jeong JH; Han HJ; Moon SY; Park KW; Han SH; Park KH; Kim HJ; Na DL; Seo SW
    J Alzheimers Dis; 2015; 46(2):399-406. PubMed ID: 25737040
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease.
    Okamura N; Arai H; Maruyama M; Higuchi M; Matsui T; Tanji H; Seki T; Hirai H; Chiba H; Itoh M; Sasaki H
    Am J Psychiatry; 2002 Mar; 159(3):474-6. PubMed ID: 11870015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Care dependency and survival among female patients with Alzheimer's disease: a two-year follow-up.
    Dijkstra A; Spisma DH; Dassen TW
    Croat Med J; 1998 Sep; 39(3):365-70. PubMed ID: 9740651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
    Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G
    J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of selection criteria used in Alzheimer's disease clinical trials.
    Willmer J; Mohr E
    Can J Neurol Sci; 1998 Feb; 25(1):39-43. PubMed ID: 9532279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are patients with Alzheimer's disease surviving longer in recent years?
    Beard CM; Kokmen E; O'Brien PC; Kurland LT
    Neurology; 1994 Oct; 44(10):1869-71. PubMed ID: 7936239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical features and mortality in patients with early-onset Alzheimer's disease.
    Samson WN; van Duijn CM; Hop WC; Hofman A
    Eur Neurol; 1996; 36(2):103-6. PubMed ID: 8654478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors associated with duration of survival in Alzheimer's disease.
    Barclay LL; Zemcov A; Blass JP; McDowell FH
    Biol Psychiatry; 1985 Jan; 20(1):86-93. PubMed ID: 3965040
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modeling the effect of Alzheimer's disease on mortality.
    Johnson E; Brookmeyer R; Ziegler-Graham K
    Int J Biostat; 2007; 3(1):Article 13. PubMed ID: 22550653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Summaries for patients. Early symptoms help predict survival time in patients with Alzheimer's disease.
    Ann Intern Med; 2004 Apr; 140(7):I26. PubMed ID: 15069002
    [No Abstract]   [Full Text] [Related]  

  • 56. Electroencephalography and survival in patients with Alzheimer's disease.
    Claus JJ; Bour LJ; Ongerboer de Visser BW
    Neurology; 1998 Sep; 51(3):918-9. PubMed ID: 9748068
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical subtypes of Alzheimer's disease.
    Tariska P; Urbanics K
    Arch Gerontol Geriatr; 1995; 21(1):13-20. PubMed ID: 15374219
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and validation of a clinical prediction tool to estimate survival in community-dwelling adults living with dementia: a protocol.
    Bonares M; Fisher S; Clarke A; Dover K; Quinn K; Stall N; Isenberg S; Tanuseputro P; Li W
    BMJ Open; 2024 Nov; 14(11):e086231. PubMed ID: 39551579
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Parallel electrophysiological abnormalities due to COVID-19 infection and to Alzheimer's disease and related dementia.
    Jiang Y; Neal J; Sompol P; Yener G; Arakaki X; Norris CM; Farina FR; Ibanez A; Lopez S; Al-Ezzi A; Kavcic V; Güntekin B; Babiloni C; Hajós M
    Alzheimers Dement; 2024 Oct; 20(10):7296-7319. PubMed ID: 39206795
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors for survival in patients with Alzheimer's disease: a large comprehensive meta-analysis.
    Zheng X; Wang S; Huang J; Li C; Shang H
    Transl Psychiatry; 2024 Apr; 14(1):184. PubMed ID: 38600070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.